WINDTREE THERAPEUTICS INC /DE/ Deferred Income Tax Expense (Benefit)
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Deferred Income Tax Expense (Benefit) of -$3.23 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ deferred income tax expense (benefit) for the quarter ending 2024-12-31 was -$210.00K.
- WINDTREE THERAPEUTICS INC /DE/ deferred income tax expense (benefit) for the quarter ending 2022-12-31 was -$1.37M.
- WINDTREE THERAPEUTICS INC /DE/ deferred income tax expense (benefit) for the quarter ending 2022-09-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ deferred income tax expense (benefit) for the quarter ending 2021-12-31 was -$1.66M.
- WINDTREE THERAPEUTICS INC /DE/ deferred income tax expense (benefit) for fiscal 2024 was -$210.00K.
- WINDTREE THERAPEUTICS INC /DE/ deferred income tax expense (benefit) for fiscal 2023 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ deferred income tax expense (benefit) for fiscal 2022 was -$1.37M.
- WINDTREE THERAPEUTICS INC /DE/ deferred income tax expense (benefit) for fiscal 2021 was -$9.99M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$3.23M 10-Q · filed 2025-11-19 | |||
| 2024-12-31 | -$210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$210.00K 10-K · filed 2025-04-15 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-19 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-04-15 | |||
| 2022-12-31 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$1.37M derived: sum of 2 quarters · filed 2024-04-16 | -$1.37M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | -$1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$1.66M derived: sum of 2 quarters · filed 2023-03-31 | -$9.96M derived: sum of 3 quarters · filed 2023-03-31 | -$9.99M 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$8.30M derived: sum of 2 quarters · filed 2022-11-14 | -$8.33M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$8.30M 10-Q · filed 2022-08-11 | -$8.33M 10-Q · filed 2022-08-11 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $0.00 10-K · filed 2022-03-31 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |